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Introduction {#sec1}
============

Centrioles are cylindrical organelles with characteristic 9-fold radial symmetry that are present in all eukaryotes, except higher plants ([@bib7]). Centrioles function in two distinct roles, close to the cell membrane as basal bodies from which cilia and flagella emanate or adjacent to the nucleus, where a centriole pair and associated pericentriolar material comprise the centrosome. The latter functions as the microtubule-organizing center in animal cells, directing formation of the mitotic spindle during division and thereby ensuring correct chromosome segregation. Both roles of centrioles are crucial for fundamental cellular processes, including signaling, motility, development, and genome stability. Defects in centriole duplication are linked to multiple diseases, including ciliopathies, male sterility, and primary microcephaly ([@bib27]).

Evolutionarily conserved proteins necessary for centriole assembly have been identified across the eukaryotic taxon ([@bib2; @bib7]), and they include CPAP/SAS-4, STIL/Ana2/SAS-5, SAS-6, and Cep135/Bld10p. In most species, SAS-6 proteins form an initial assembly close to the parental centriole, the "cartwheel," with a ring-like hub and radially projecting spokes ([@bib26]). In vitro studies of the *Chlamydomonas reinhardtii* and *Danio rerio* SAS-6 orthologs ([@bib16; @bib36]) found that they self-assemble into rings with spokes composed of coiled coils. Cryo-tomographic studies of isolated *Trichonympha sp.* centrioles showed that multiple cartwheels can stack together with periodicity of 8 nm along the long centriolar axis, whereas the spokes of adjacent cartwheels merge at approximately midlength to form coiled-coil bundles every 17 nm ([@bib9]).

Following cartwheel assembly, CPAP/SAS-4 (also known as CENPJ) ([@bib17; @bib31; @bib32]) localizes to the site of the growing centriole ([@bib18; @bib25]). CPAP and its orthologs are endowed with multiple functions: its N terminus interacts with pericentriolar proteins ([@bib8]), including γ-tubulin ([@bib13]), it harbors microtubule and tubulin association epitopes ([@bib5; @bib12; @bib14]), and it is required for microtubule attachment to the initial centriolar scaffold ([@bib29]). Interestingly, CPAP overexpression leads to abnormally long centrioles ([@bib17; @bib31; @bib32]), whereas mutations in CPAP can cause autosomal recessive primary microcephaly, MCPH, a developmental disorder that leads to reduced brain size and associated mental retardation ([@bib35]). Other proteins whose variants lead to MCPH include STIL ([@bib1]) and Cep135 ([@bib28]). STIL is an essential centriolar component that interacts with CPAP ([@bib15; @bib33; @bib37]), is required for CPAP and SAS-6 ([@bib37]) centriolar localization, and shuttles rapidly between centrioles and the cytoplasm ([@bib37]). Cep135 interacts directly with SAS-6, CPAP, and microtubules ([@bib3; @bib22]), whereas Bld10p, the *C. reinhardtii* Cep135 ortholog, localizes to "pinhead" structures that bridge the SAS-6 cartwheel and centriolar microtubule triplets ([@bib11]).

Despite the importance of CPAP in centriole assembly, we lack information about the structural features of this protein or the mechanisms that position it in the centriole. Here, we determine the crystallographic structure of the conserved C-terminal domain of CPAP, termed the G-box, alone or in complex with a STIL fragment. The surprising features of the G-box domain, along with information on the molecular architecture of CPAP allow us to propose a specific role for this protein in the centriole ultrastructure.

Results {#sec2}
=======

Molecular Architecture of CPAP {#sec2.1}
------------------------------

Human CPAP (HsCPAP) is a 1338 amino acids protein with a glycine-rich C-terminal domain (G-box) ([Figure 1](#fig1){ref-type="fig"}A). Previous work showed that separate HsCPAP motifs bind tubulin heterodimers and destabilize microtubules (PN2-3) ([@bib5; @bib14]) or bind and stabilize microtubules (A5N) ([@bib12]). PN2-3, A5N, and the G-box are the most conserved regions between HsCPAP and its functional orthologs in *D. rerio*, *Drosophila melanogaster*, and *Caenorhabditis elegans* ([@bib8; @bib15; @bib33]). All four orthologs also feature a predicted ∼150--200 residue coiled coil adjacent to the G-box; in contrast, the three N-terminal coiled coils of HsCPAP are not universally predicted, and they are presumed to be of low stability or unstructured as judged by their short length and biophysical properties ([@bib5]).

Recombinantly produced HsCPAP coiled-coil domain (HsCPAP~CC~, residues 897--1,056) exhibits circular dichroism (CD) spectra with the double minima characteristic of α-helical proteins ([Figure 1](#fig1){ref-type="fig"}B) and a cooperative transition profile upon thermal denaturation ([Figure 1](#fig1){ref-type="fig"}C), evidence which support the prediction of an independently folded coiled coil. Size-exclusion chromatography-multiangle light scattering (SEC-MALS) showed that HsCPAP~CC~ is dimeric in solution ([Figure 1](#fig1){ref-type="fig"}D). In order to evaluate the relative orientation of the monomeric subunits in the dimer, we performed crosslinking experiments. The sole cysteine in HsCPAP~CC~ is one added during cloning at the protein C terminus; thus, it can form a disulfide with its dimer counterpart only if the coiled coil is parallel. As shown in [Figure 1](#fig1){ref-type="fig"}E, HsCPAP~cc~ migrates as a dimer in SDS-PAGE under nonreducing conditions, thereby supporting a parallel orientation ([Figure 1](#fig1){ref-type="fig"}I). The length of this ∼160 residue coiled coil, if linear, can be calculated as ∼24 nm.

Furthermore, we produced the G-box domains of HsCPAP (HsCPAP~G-box~) and *D. rerio* CPAP (DrCPAP~G-box~); these are well conserved with 64.5% sequence identity, based on that we expect the two domains to have high structural similarity. Both G-box domains are monomeric under dilute conditions, as determined by SEC-MALS ([Figure 1](#fig1){ref-type="fig"}H; [Figure S1](#app3){ref-type="sec"}C available online) and display CD spectra characteristic of β strand proteins ([Figures 1](#fig1){ref-type="fig"}F and [S1](#app3){ref-type="sec"}A). However, DrCPAP~G-box~ shows significantly more cooperativity upon thermal unfolding compared to HsCPAP~G-box~ ([Figures 1](#fig1){ref-type="fig"}G and [S1](#app3){ref-type="sec"}B, respectively). As higher unfolding cooperativity may reflect lower protein plasticity, this property recommended DrCPAP~G-box~ for crystallographic studies.

Structure of the CPAP G-Box Domain {#sec2.2}
----------------------------------

Next, we determined the structure of the G-box domain. DrCPAP~G-box~ crystals formed readily and diffracted to 1.44 Å resolution ([Table 1](#tbl1){ref-type="table"}). The final model, refined to R/R~free~ of 15.4%/18.0%, consists of one molecule per asymmetric unit and accounts for DrCPAP residues 950--1,106 ([Table 1](#tbl1){ref-type="table"}). The first 7 and last 15 residues of DrCPAP~G-box~ were not observed in the electron density, despite being present in the expressed construct as confirmed with mass spectrometry; therefore, they are presumed disordered in the crystal.

DrCPAP~G-box~ consists of 17 antiparallel β strands that form a ∼75 Å long and ∼23 Å wide β sheet, with an ∼168° of twist across its length ([Figures 2](#fig2){ref-type="fig"}A and 2B). Remarkably, all residues of this structure are solvent exposed; thus, it lacks a well-defined hydrophobic core. A search for similar structures in the Protein Data Bank shows that only OspA, which features a large exposed β sheet ([@bib23]), is structurally related. However, DrCPAP~G-box~ does not include globular domains capping the β sheet, in contrast to OspA, yet it remains highly soluble and cooperatively folded ([Figure 1](#fig1){ref-type="fig"}G). Analysis of the model suggests that DrCPAP~G-box~ is stabilized through a number of interstrand ionic interactions ([Figure 2](#fig2){ref-type="fig"}C), as well as through clusters of hydrophobic residues that span multiple β strands ([Figure 2](#fig2){ref-type="fig"}D). In addition, significant burial of hydrophobic surface area occurs between nonpolar side chains and the aliphatic part of long polar groups, such as arginine and lysine residues. To better understand DrCPAP~G-box~ stability, we performed a 100 ns atomistic molecular dynamics simulation starting from the crystallographic structure. As shown in [Figure S2](#app3){ref-type="sec"}, DrCPAP~G-box~ remains folded during the simulation with no signs of β sheet unraveling. The domain length ([Figure S2](#app3){ref-type="sec"}A), the number of main chain hydrogen bonds formed ([Figure S2](#app3){ref-type="sec"}B), and the hydrophobic area buried ([Figure S2](#app3){ref-type="sec"}C) remain essentially unaltered throughout the simulation trajectory ([Figure S2](#app3){ref-type="sec"}D; [Movie S1](#mmc2){ref-type="supplementary-material"}).

DrCPAP~G-box~ domains associate through a head-to-tail interaction in the crystal along the open ends of β1 and β17, which involves formation of five hydrogen bonds and burial of ∼420 Å^2^ of surface area. This interaction creates a continuous β sheet with ∼8 nm periodicity, reminiscent of amyloid fibrils ([Figure 2](#fig2){ref-type="fig"}E). To establish whether DrCPAP~G-box~ populates such supramolecular structures in solution, we performed dynamic light scattering (DLS) measurements. As shown in [Figures 2](#fig2){ref-type="fig"}F and 2G, DrCPAP~G-box~ forms assemblies of increasing hydrodynamic radius as a function of protein concentration. We conclude that DrCPAP~G-box~ is inherently able to form large assemblies in solution, in a manner likely similar to the fibrils observed in the crystal.

Characterization of the CPAP-STIL Interaction {#sec2.3}
---------------------------------------------

Previous studies using yeast-two-hybrid and pull-down assays had shown that a HsCPAP fragment spanning the coiled-coil and G-box domains interacts with the central region of human STIL (HsSTIL) ([@bib33]). This interaction is attenuated in the presence of a missense mutation, E1235V, which maps on the G-box and can lead to MCPH ([@bib35]). Using fluorescence polarization, we sublocalized this interaction to HsCPAP~G-box~ and a short HsSTIL fragment that spans residues 385--433 ([Figure 3](#fig3){ref-type="fig"}A). Whereas the wild-type proteins interact with a K~d~ of 0.55 ± 0.06 μM, HsCPAP~G-box~ E1235V and E1235K, a more radical substitution that inverts the electrostatic charge, bind the same HsSTIL region with 9- and 75-fold lower affinity, respectively ([Figure 3](#fig3){ref-type="fig"}A). Sequence alignments of STIL orthologs, as well as the STIL relatives of *C. elegans* (SAS-5) and *D. melanogaster* (Ana2), showed the presence of a conserved proline-rich motif on HsSTIL residues 404--413 ([Figure S3](#app3){ref-type="sec"}B). A HsSTIL fragment lacking this motif (residues 420--475) showed an ∼25-fold decrease in HsCPAP~G-box~ affinity ([Figure 3](#fig3){ref-type="fig"}B). We conclude that the conserved proline-rich motif of HsSTIL is important for binding to HsCPAP~G-box~; furthermore, as this motif is present in the STIL relatives SAS-5 and Ana2, the case for functional orthology between these molecules is strengthened.

Structure of the CPAP~G-Box~-STIL Complex {#sec2.4}
-----------------------------------------

We determined the structure of the CPAP-STIL complex using *D. rerio* STIL (DrSTIL) fragments that span residues 398--450 or 414--428 (equivalent to HsSTIL residues 385--433 and 401--415, respectively). Crystals of the later peptide in complex with DrCPAP~G-box~ diffracted to 1.72 Å resolution ([Table 1](#tbl1){ref-type="table"}), and they provided unambiguous electron density difference for DrSTIL following molecular replacement with DrCPAP~G-box~ ([Figure S3](#app3){ref-type="sec"}C). This density allowed us to identify specific peptide residues; however, the final model, refined to R/R~free~ of 19.0%/21.3%, shows just eight DrSTIL residues that make significant contact with DrCPAP~G-box~. In contrast, crystals of DrCPAP~G-box~ in complex with DrSTIL residues 398--450, which diffracted to 2.44 Å resolution ([Table 1](#tbl1){ref-type="table"}), yielded more widespread peptide density. Thus, we were able to fit 16 DrSTIL residues (413--428, equivalent to HsSTIL residues 400--415), using the peptide register established from the 1.72 Å resolution complex, and refine the resulting model to R/R~free~ of 19.8%/21.4% ([Figures 3](#fig3){ref-type="fig"}C and [S3](#app3){ref-type="sec"}D).

The interface revealed spans approximately half of the G-box β sheet, from the N terminus of that domain to just beyond the MCPH glutamate (E1021 in DrCPAP). DrCPAP~G-box~ remains essentially unaltered upon complex formation, with a C~α~ root-mean-square deviation (rmsd) of just 0.79 Å compared to DrCPAP~G-box~ alone. The G-box domain still forms β sheet fibrils in the crystal with no differences in their register or spacing. On DrSTIL, the complex involves the proline-rich motif identified above. Complex formation buries ∼790 Å^2^ of accessible surface area, and it is stabilized by six putative hydrogen bonds; two of these are formed between the E1021 side chain and the DrSTIL H424 backbone. Analysis of the structure suggests that hydrophobic surface burial is important to complex stability, with DrSTIL residues P417, P421, and P423 packing against DrCPAP F978, Y996, and F1015, respectively ([Figure 3](#fig3){ref-type="fig"}D). Similarly, DrSTIL R418 is involved in stacking and hydrogen bonding interactions with DrCPAP Y994, Y996, and H1003 ([Figure 3](#fig3){ref-type="fig"}D). Amino acid substitutions at these positions reduce complex stability, as shown in fluorescence polarization measurements ([Figure 3](#fig3){ref-type="fig"}A), using HsCPAP~G-box~ Y1208A (equivalent to DrCPAP Y994), Y1210A (DrCPAP Y996), and F1229A (DrCPAP F1015). HsSTIL R405I (DrSTIL R418), a relatively conservative substitution that should maintain hydrophobic interactions but perturb the stacking arrangement and hydrogen bonding also results in significant reduction in affinity ([Figure 3](#fig3){ref-type="fig"}B).

DrSTIL electron density in the 2.44 Å resolution complex terminates abruptly where crystallographic symmetry-related molecules pack. To determine whether additional DrSTIL residues interact with DrCPAP~G-box~ in solution, we performed nuclear magnetic resonance (NMR) experiments. Titrations of unlabeled DrCPAP~G-box~ to ^15^N-labeled DrSTIL residues 398--450 yielded the progressive disappearance of amide resonances because of the slow tumbling rate of the resulting complex ([Figure S3](#app3){ref-type="sec"}F). Analysis of NMR resonance intensities suggests that DrCPAP~G-box~ engages DrSTIL residues 413--449 (equivalent to HsSTIL residues 400--436; [Figure S3](#app3){ref-type="sec"}E). To test this suggestion, we substituted HsSTIL residue K419, which is outside the STIL region observed in the crystallographic complex structure yet is conserved or conservatively substituted in all vertebrates. Fluorescence polarization experiments show that HsSTIL K419E significantly reduces affinity for HsCPAP~G-box~ ([Figure 3](#fig3){ref-type="fig"}B). Thus, we surmise that in solution the complex likely spans the entire length of the CPAP G-box.

Discussion {#sec3}
==========

Centrioles have fascinated biologists for decades; however, only recently have studies started to elucidate the mechanistic roles of their components. An emerging feature is the structural and functional similarity of their protein components despite sequence divergence ([@bib7]). The CPAP~G-box~-STIL complex is a case in point: STIL and its proposed relatives SAS-5 and Ana2 share little identity making their linkage on the basis of sequence difficult. However, our results suggest that they all contain a conserved CPAP/SAS-4 interaction motif, including universally unaltered residues ([Figure S3](#app3){ref-type="sec"}B). Together with the suggestion of a SAS-6 binding motif in STIL/Ana2/SAS-5 ([@bib10; @bib30]), these results support the notion of widespread functional conservation between centriole proteins.

At the same time, structural studies can place components in the larger centriolar assembly. SAS-6 proteins were shown to self-assemble into cartwheels ([@bib16; @bib36]), whereas multiple cartwheels stack together forming a cylindrical scaffold ([@bib9]). The focus now turns on how microtubules attach to this initial scaffold and how centrioles elongate. CPAP/SAS-4 appears to be implicated in both processes, as its depletion prevents microtubule recruitment ([@bib29]), but its overexpression leads to very long centrioles ([@bib17; @bib31]). CPAP/SAS-4 is placed close to centriolar microtubules, both by superresolution microscopy studies that tracked the protein N terminus ([@bib25]) and C terminus ([@bib18]), and by interaction studies, which showed that the HsCPAP C terminus associates with Cep135 ([@bib22]). Our structural studies offer an intriguing possibility that integrates the aforementioned properties into a mechanistic role for CPAP in the centriole ultrastructure.

A previous cryo-tomographic study of purified *C. reinhardtii* basal bodies showed distinct electron densities in the vicinity of the microtubule wall ([@bib21]). We propose that CPAP accounts for an elongated density observed there that lies roughly parallel to the microtubule triplet ([Figures 4](#fig4){ref-type="fig"}A and 4B). The CPAP C terminus, which interacts with Cep135 ([@bib22]), would be placed close to the A-tubule as part of the overall "pinhead" assembly that connects cartwheels to microtubules, and where Cep135/Bld10p also locates ([@bib11]). The 24-nm-long CPAP coiled coil would then stretch approximately to the beginning of the C-tubule, where the CPAP N terminus could form connections through its microtubule associating segments ([@bib12]). Thus, we propose that CPAP acts as a horizontal "strut," linking the pinhead with microtubules and reinforcing the overall centriole assembly. It is possible that differences in CPAP length among organisms are related to apparent differences in microtubule tilt with respect to cartwheel spokes; however, further modeling efforts would be required to assess this hypothesis.

G-box domains were shown to form fibrillar structures with ∼8 nm periodicity ([Figure 2](#fig2){ref-type="fig"}E), which is proportional to the size of the tubulin heterodimer and approximately half of the vertical span between successive cartwheel spokes ([@bib9]). We propose that the G-box domains of the CPAP dimer bridge that span by associating in a head-to-tail arrangement ([Figure 4](#fig4){ref-type="fig"}C); the relatively long linkers connecting the G-box and coiled-coil domains allow for this domain orientation to occur ([Figure 1](#fig1){ref-type="fig"}I). G-box domains of successive CPAP dimers would thus link into a continuous fibril in a manner analogous to that observed in the crystal, thereby providing vertical connections and complementing the horizontal strut role outlined above. We believe that the periodicity of the G-box fibril is no coincidence and that it may act as a "molecular ruler" for the initial centriolar scaffold prior to microtubule attachment. Furthermore, excessive CPAP amounts in the cell likely would allow formation of longer G-box fibrils, hence driving the creation of abnormally long centrioles.

What is the role of STIL in this mechanistic picture? Fluorescence recovery after photobleaching assays in human ([@bib37]) and *C. elegans* ([@bib6]) cells showed that STIL/SAS-5 transits rapidly between centrioles and the cytoplasm; this is in contrast to SAS-6 ([@bib20]) or SAS-4 ([@bib19]), the fluorescence of which recovers very slowly. This property suggests that STIL does not form permanent structural connections to centrioles as SAS-6 and CPAP do, but rather it may act as a transporter molecule for these components ([Figure 4](#fig4){ref-type="fig"}A). The MCPH-causing HsCPAP E1235V mutation reduces CPAP-STIL affinity and thus may reduce the rate of CPAP transport. Although centriole duplication is ultimately little affected in this HsCPAP variant ([@bib15]), the reduced rate of CPAP accumulation may be the basis of MCPH.

In summary, our findings suggest an intriguing structural role for CPAP in centriole assembly. Observing the unusual means, such as G-box domains, by which nature has overcome mechanistic challenges in building this assembly is fascinating.

Experimental Procedures {#sec4}
=======================

Details of the experimental procedures are provided in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}. Briefly, G-box domains were produced by glutathione affinity and gel filtration chromatography, whereas HsCPAP~CC~ and STIL fragments were purified by metal affinity and gel filtration chromatography or were made synthetically. For fluorescence polarization, STIL fragments were derivatized with 5-FAM. Biophysical experiments were performed at 20°C in PBS buffer supplemented with DTT, with the exception of HsCPAP~CC~ crosslinking for which no DTT was added. NMR sequential assignments were performed using triple resonance experiments, and they have been deposited to the BioMagResBank under accession number 19318. Protein crystals were obtained by the sitting drop vapor diffusion technique at 20°C. For Sm-derivatization, crystals were incubated with 10 mM SmCl~3~ for 1 hr. Phase information for DrCPAP~G-box~ was obtained using the single-wavelength anomalous diffraction method, whereas DrCPAP~G-box~-DrSTIL complexes were solved by molecular replacement. Crystallographic data processing and refinement statistics are provided in [Table 1](#tbl1){ref-type="table"}. The model and associated data have been deposited in the RCSB Protein Data Bank under the accession numbers [4LD1](pdb:4LD1){#intref0010} (DrCPAP~G-box~), [4LD3](pdb:4LD3){#intref0015} (DrCPAP~G-box~-DrSTIL residues 398--450), and [4LZF](pdb:4LZF){#intref0020} (DrCPAP~G-box~-DrSTIL residues 414--428). Details of molecular dynamics simulations are provided in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Accession Numbers {#app1}
=================

The RCSB accession numbers for the structures of DrCPAP~G-box~ alone, in complex with a DrSTIL residues 398--450 fragment, or in complex with a DrSTIL residues 414--428 fragment are [4LD1](pdb:4LD1){#intref0025}, [4LD3](pdb:4LD3){#intref0030}, and [4LZF](pdb:4LZF){#intref0035}, respectively. The BioMagResBank accession number for the sequence-specific NMR assignments of DrSTIL residues 398--450 is 19318.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S3Movie S1. Molecular Dynamics Simulation DrCPAP~G-box~, Related to Figure 2Visualization of the DrCPAPG-box molecular dynamics simulation trajectory, with individual frames corresponding to snapshots extracted every 1 ns. We observe significant bending and twisting of the β sheet, suggesting that DrCPAPG-box has inherent plasticity in solution.3D Molecular Model S1. Crystal Structure of the DrCPAP G-box Domain, Related to Figure 23D Molecular Model S2. Structure of the DrCPAP G-box Domain in Complex with a DrSTIL Fragment: C2 Crystal Form, Related to Figure 33D Molecular Model S3. Structure of the DrCPAP G-box Domain in Complex with a DrSTIL Fragment; P32 Crystal Form, Related to Figure 3
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![Molecular Architecture of HsCPAP\
(A) Schematic representation of CPAP/SAS-4 from human, *D. rerio*, *D. melanogaster*, and *C. elegans*. Orange, yellow, and red boxes correspond to the protein tubulin binding (PN2-3), microtubule binding (A5N), and G-box domains, respectively. The predicted coiled-coil domains are indicated by green helices; the long coiled coil adjacent to the G-box features a short break in some species. Residue boundaries and the extent of our protein constructs are indicated. Asterisks in HsCPAP denote the location of MCPH causing mutations; M1 and M2 correspond to premature stop codons.\
(B and C) CD spectrum of HsCPAP~CC~ (B) and change in molar elipticity (C) at 222 nm showing a cooperative transition upon thermal unfolding of the same construct are shown.\
(D) SEC-MALS analysis of HsCPAP~CC~. The UV absorbance profile from SEC (black line) is overlain with the MALS estimation of molecular mass (red line), which agrees well with that of a dimer (39.5 kDa).\
(E) SDS-PAGE of HsCPAP~CC~ under reducing (+βMe) and nonreducing (−βMe) conditions. Arrowheads point to protein bands corresponding to monomeric (M) and disulfide-linked dimeric (D) forms.\
(F and G) CD spectra (F) and thermal unfolding profile (G) at 218 nm of DrCPAP~G-box~ are shown.\
(H) SEC-MALS analysis of DrCPAP~G-box~ as in (D). The estimated molecular mass agrees well with a momoner (20.8 kDa).\
(I) Molecular model of CPAP with a parallel coiled coil and a C-terminal domain connected by a flexible linker is shown.\
See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![Structural Analysis of DrCPAP~G-box~\
(A and B) Shown is schematic representation of DrCPAP~G-box~ in two perpendicular views. The secondary structure elements, protein dimensions, and the β sheet twist are shown.\
(C and D) Electrostatic (C) and hydrophobic (D) interactions on the surface of the DrCPAP~G-box~ β sheet are shown. The residues involved are shown in CPK and space-filling representation, respectively.\
(E) Schematic representation of the DrCPAP~G-box~ fibril. Three successive G-box domains are colored pink, blue, and green, with the β1 and β17 strands and the fibril periodicity shown.\
(F) Distributions of hydrodynamic radii (R~h~) of DrCPAP~G-box~ assemblies in solution at three different concentrations as measured by DLS. The distributions are broad, with large assemblies populated even at the lowest concentration (blue line); their prevalence increases as a function of protein concentration.\
(G) Mean R~h~ of DrCPAP~G-box~ assemblies by DLS as a function of protein concentration. R~h~ at the infinite dilution point (pink square) was calculated from the DrCPAP~G-box~ structure. Error bars correspond to one SD from triplicate measurements.\
See also [Figure S2](#app3){ref-type="sec"} and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr2){#fig2}

![Biophysical and Structural Analysis of the DrCPAP~G-box~-DrSTIL Complex\
(A and B) Quantification of the HsCPAP~G-box~-HsSTIL interaction by fluorescence polarization experiments is shown. The binding saturation of fluorescently labeled HsSTIL fragments is plotted against HsCPAP~G-box~ concentration. Solid lines are fits to a 1:1 association model. (A) Shows HsCPAP~G-box~ variants binding to wild-type HsSTIL residues 385--433. (B) Shows wild-type HsCPAP~G-box~ binding to HsSTIL residues 419--475 or HsSTIL residues 385--433 variants. The F1229A variant of HsCPAP, and the R405I and K419E variants of HsSTIL could not be fit satisfactorily.\
(C) Electrostatic surface representation of DrCPAP~G-box~ with a DrSTIL fragment as sticks. The DrSTIL N termini and C termini are indicated. The complex shown was obtained using DrSTIL residues 398--450.\
(D) Hydrophobic interactions between DrCPAP~G-box~ and DrSTIL. Residues involved in interactions are shown in space-filling representation in blue (DrCPAP~G-box~) or orange (DrSTIL).\
See also [Figure S3](#app3){ref-type="sec"}.](gr3){#fig3}

![The Role of CPAP/SAS-4 in the Centriole Ultrastructure\
(A) Schematic top view of the centriolar assembly, showing the SAS-6 cartwheel, pinheads (orange) connecting the cartwheel to microtubule triplets, and our proposed location of CPAP (gray). STIL may act as transporter of SAS-6 and CPAP to the growing centriole.\
(B) View of an area close to microtubules, boxed in (A). The end of the SAS-6 spoke connects to the pinhead, where Cep135 locates. Cep135 interacts with the CPAP C terminus (green), whereas the CPAP coiled coil projects parallel to the microtubule triplet. The microtubule-interacting epitope of CPAP (A5N) can form connections to the B-tubule and C-tubule.\
(C) Side view of a centriole section, showing the vertical spacing of SAS-6 spokes as they merge together, the pinhead and A-tubule connection, as well as our proposed fibril of CPAP G-box domains crosslinking cartwheel stacks on the vertical axis.](gr4){#fig4}

###### 

Crystallographic Data Collection and Refinement Statistics

  Protein                                                  DrCPAP~G-box~                                 DrCPAP~G-box~ (Sm Derivative)                 DrCPAP~G-box~-DrSTIL Residues 398--450        DrCPAP~G-box~-DrSTIL Residues 414--428
  -------------------------------------------------------- --------------------------------------------- --------------------------------------------- --------------------------------------------- ----------------------------------------------
  PDB ID code                                              [4LD1](pdb:4LD1){#intref0045}                 --                                            [4LD3](pdb:4LD3){#intref0050}                 [4LZF](pdb:4LZF){#intref0055}
  Space group                                              P1 2~1~ 1                                     P1 2~1~ 1                                     P3~2~                                         C1 2~1~ 1
  Unit cell (Å, °)                                         a = 41.62, b = 50.25, c = 60.34, β = 108.56   a = 41.74, b = 50.58, c = 60.29, β = 108.97   a = 79.97, b = 79.97, c = 52.27, γ = 120.00   a = 97.58, b = 38.39, c = 70.05, β = 126.68
  Beamline                                                 DLS/I02                                       DLS/I03                                       DLS/I02                                       DLS/I02
  Wavelength (Å)                                           0.9795                                        1.595                                         0.9795                                        0.9795
  Resolution range (Å)                                     39.47--1.44                                   57.02--1.80                                   28.87--2.44                                   48.42--1.72
  High-resolution shell (Å)                                1.49--1.44                                    1.85--1.80                                    2.50--2.44                                    1.76--1.72
  *R*~Merge~[a](#tblfn1){ref-type="table-fn"}              0.026 (0.504)                                 0.076 (0.571)                                 0.051 (0.784)                                 0.026 (0.656)
  *R*~*Pim*~[a](#tblfn1){ref-type="table-fn"}              0.024 (0.453)                                 0.032 (0.316)                                 0.029 (0.427)                                 0.023 (0.365)
  Completeness[a](#tblfn1){ref-type="table-fn"} (%)        99.3 (99.9)                                   90.4 (51.2)                                   98.0 (97.7)                                   90.2 (54.2)[b](#tblfn2){ref-type="table-fn"}
  Multiplicity[a](#tblfn1){ref-type="table-fn"}            3.7 (3.7)                                     12.4 (7.7)                                    5.1 (5.3)                                     2.9 (1.9)
  I/σ(I)[a](#tblfn1){ref-type="table-fn"}                  19.2 (2.3)                                    17.8 (2.9)                                    12.7 (1.8)                                    19.5 (2.1)
  Phasing                                                                                                                                                                                            
  No. of Sm sites                                          --                                            2                                             --                                            --
  Resolution                                               --                                            57.02--1.80                                   --                                            --
  FOM initial[c](#tblfn3){ref-type="table-fn"}             --                                            0.21                                          --                                            --
  FOM DM[d](#tblfn4){ref-type="table-fn"}                  --                                            0.94                                          --                                            --
  Refinement statistics                                                                                                                                                                              
  *R*~work~ (reflections)                                  0.154 (42,575)                                --                                            0.198 (11,691)                                0.190 (19,069)
  *R*~*f*ree~ (reflections)                                0.180 (2,156)                                 --                                            0.214 (613)                                   0.231 (1,022)
  Number of atoms                                                                                                                                                                                    
  Protein atoms[e](#tblfn5){ref-type="table-fn"}           2,688                                         --                                            1,362                                         1,367
  Ligands                                                  39                                            --                                            21                                            33
  Water                                                    204                                           --                                            3                                             99
  Average B factors (Å^2^)                                                                                                                                                                           
  Protein atoms                                            33.8                                          --                                            113.4                                         40.8
  Water                                                    46.2                                          --                                            90.5                                          50.6
  Rmsd from ideal values                                                                                                                                                                             
  Bonds/angles (Å/°)                                       0.009/1.20                                    --                                            0.010/1.08                                    0.006/1.11
  MolProbity statistics[f](#tblfn6){ref-type="table-fn"}                                                                                                                                             
  Ramachandran favored (%)                                 99.35                                         --                                            98.80                                         98.77
  Ramachandran disallowed (%)                              0.0                                           --                                            0.0                                           0.0
  Clashscore (percentile)                                  4.04 (95%)                                    --                                            3.69 (99%)                                    4.34 (96%)
  MolProbity score (percentile)                            1.19 (97%)                                    --                                            1.16 (100%)                                   1.21 (98%)

Values in parentheses correspond to the high-resolution shell.

Reflection data are 99.4% complete to a resolution of 1.99 Å.

From PHASER ([@bib24]).

From RESOLVE ([@bib34]).

Atom count includes hydrogens in the P1 2~1~ 1 model.

[@bib4].
